Pandit, Vikram S. – Trademark Portfolio

Entity Type: 01

Pandit, Vikram S. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include OROGEN. The owner is based in New York, NY.

310 E. 53rd Street, 29th Floor

New York, NY 10022

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

OROGEN
OROGEN
Registered 2016
SONNERIE
SONNERIE
Cancelled 2013

Trademark Classifications

Pandit, Vikram S.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

36
Insurance & Financial (1 filing)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does Pandit, Vikram S. have?

Pandit, Vikram S. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.

What trademark classes does Pandit, Vikram S. file in?

Pandit, Vikram S. files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 36 (Insurance & Financial). Class 35 covers advertising; business management; business administration; office functions.

What are Pandit, Vikram S.'s most well-known trademarks?

Pandit, Vikram S.'s registered trademark portfolio includes well-known marks such as OROGEN. These are among 1 currently registered trademark in the portfolio.

What is Pandit, Vikram S.'s trademark registration success rate?

Pandit, Vikram S. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.